Evidence map›Paper›PMID 42077117›Full record

ArticleBioethics2026

Enhancement, Autonomy, and the Limits of Beneficence.

K Lindsey Chambers

Abstract read
In one paragraph

Article in Bioethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

K Lindsey ChambersPhilosophy Department, University of Kentucky, Lexington, Kentucky, USA.ORCID https://orcid.org/0000-0001-8747-2294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Procreative enhancement involves someone making a choice about what genetic trait(s) another person will have. Such control over the body (and mind) of another person, even if done for the recipient's benefit, threatens to overstep the moral boundary between persons. The use of genetic interventions to "enhance" one's offspring without their consent may violate that person's future autonomy. Schaefer, Kahane, and Savulescu argue, however, that the value of autonomy supports at least one class of procreative enhancements: those aimed at enhancing a future person's autonomy by improving their cognitive functioning. I argue that Schaefer et al.'s case for enhancing autonomy rests on a mistaken view about how autonomy bears on our moral obligations. They collapse the value of autonomy into the value of beneficence, or the value of promoting a person's well-being. I will show that while so-called autonomy enhancements may promote a future person's well-being, they cannot make a person more autonomous. Attempts to enhance a future person's autonomy by way of genetic modification instead constitute a violation of that person's autonomy.

Indexed as

BeneficenceGenetic EnhancementMoral ObligationsPersonal AutonomyChoice BehaviorHumansautonomybeneficencechildrenenhancementparents

Identifiers

PMID42077117
PMCPMC13570771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.